Company family · HQ SI
Krka: medicine shortages
KRKG · Ljubljana
As of 2 Nov 2026, 187 Krka products have a reported shortage across 9 countries, covering 67 medicines.
Products short187rank #13 of 464
Medicines67active ingredients
Countries9/16
New in 90 days69+25 vs market pace
Typical duration6 monthsmedian so far
Manufacturing52%demand-driven 14%
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
When its current shortages began
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Sertraline | 14 | 6 Mar 2025 | Not stated | 11/16 | |
| Enalapril | 13 | 8 Apr 2025 | Not stated | 8/16 | |
| Lenalidomide | 10 | 11 Jul 2024 | Not stated | 10/16 | |
| Repaglinide | 9 | 10 Apr 2026 | Not stated | 5/16 | |
| Quetiapine | 8 | 13 Jul 2023 | Manufacturing problem | 12/16 | |
| Rivastigmine | 7 | 21 Mar 2024 | Manufacturing problem | 6/16 | |
| Darunavir | 6 | 10 Jun 2025 | Manufacturing problem | 4/16 | |
| Duloxetine | 6 | 2 Jul 2026 | Increased demand | 12/16 | |
| Lacosamide | 6 | 6 Apr 2025 | Not stated | 6/16 | |
| Terazosin | 6 | 8 Nov 2024 | Other | 4/16 | |
| Etoricoxib | 5 | 19 Aug 2026 | Other | 7/16 | |
| Paliperidone | 5 | 19 Jul 2024 | Manufacturing problem | 11/16 | |
| Atorvastatin | 4 | 13 Feb 2025 | Not stated | 11/16 | |
| Metoprolol | 4 | 8 Oct 2024 | Manufacturing problem | 9/16 | |
| Tadalafil | 4 | 14 Sep 2026 | Not stated | 10/16 | |
| Capecitabine | 3 | 1 Jun 2026 | Manufacturing problem | 6/16 | |
| Ivabradine | 3 | 26 Feb 2026 | Not stated | 9/16 | |
| Tapentadol | 3 | 19 Feb 2026 | Not stated | 3/16 | |
| Tramadol | 3 | 25 Mar 2026 | Not stated | 7/16 | |
| Atorvastatin and Ezetimibe | 2 | 1 Oct 2026 | Other | 6/16 | |
| Celecoxib | 2 | 23 Sep 2026 | Not stated | 8/16 | |
| Desloratadine | 2 | 2 Apr 2026 | Other | 7/16 | |
| Escitalopram | 2 | 13 Oct 2026 | Manufacturing problem | 10/16 | |
| Memantine | 2 | 15 Mar 2026 | Manufacturing problem | 8/16 | |
| Mirtazapine | 2 | 9 Apr 2025 | Not stated | 10/16 | |
| Moxifloxacin | 2 | 1 Mar 2026 | Manufacturing problem | 8/16 | |
| Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide | 2 | 28 Sep 2026 | Other | 3/16 | |
| Pantoprazole | 2 | 2 Sep 2024 | Manufacturing problem | 9/16 | |
| Perindopril and Amlodipine | 2 | 24 Aug 2026 | Other | 5/16 | |
| Pregabalin | 2 | 1 Jun 2025 | Not stated | 11/16 | |
| Rabeprazole | 2 | 1 Apr 2024 | Manufacturing problem | 5/16 | |
| Ramipril | 2 | 17 Aug 2026 | Manufacturing problem | 10/16 | |
| Ranolazine | 2 | 1 Apr 2024 | Manufacturing problem | 4/16 | |
| Ropinirole | 2 | 31 Mar 2026 | Manufacturing problem | 8/16 | |
| Sitagliptin | 2 | 12 Oct 2026 | Increased demand | 8/16 | |
| Solifenacin | 2 | 14 Mar 2025 | Manufacturing problem | 6/16 | |
| Tenofovir Disoproxil and Emtricitabine | 2 | 1 May 2024 | Other | 5/16 | |
| Alprazolam | 1 | 15 Jul 2026 | Not stated | 6/16 | |
| Aripiprazole | 1 | 12 May 2026 | Manufacturing problem | 9/16 | |
| Azithromycin | 1 | 19 Mar 2026 | Not stated | 9/16 | |
| Bisoprolol | 1 | 28 Oct 2026 | Not stated | 6/16 | |
| Clopidogrel | 1 | 10 Nov 2025 | Manufacturing problem | 9/16 | |
| Dabigatran Etexilate | 1 | 19 Mar 2026 | Not stated | 10/16 | |
| Dasatinib | 1 | 29 Jan 2026 | Not stated | 6/16 | |
| Donepezil | 1 | 27 May 2026 | Increased demand | 8/16 | |
| Emtricitabine, Tenofovir Disoproxil and Efavirenz | 1 | 10 Oct 2025 | Other | 4/16 | |
| Enalapril and lercanidipine | 1 | 28 Sep 2026 | Manufacturing problem | 2/16 | |
| Erlotinib | 1 | 2 Jul 2025 | Not stated | 5/16 | |
| Galantamine | 1 | 30 May 2026 | Increased demand | 7/16 | |
| Irbesartan | 1 | 23 Apr 2026 | Not stated | 6/16 | |
| Lansoprazole | 1 | 5 Apr 2026 | Manufacturing problem | 8/16 | |
| Levetiracetam | 1 | 26 Aug 2026 | Manufacturing problem | 9/16 | |
| Levofloxacin | 1 | 9 Jan 2026 | Not stated | 4/16 | |
| Metformin and Vildagliptin | 1 | 22 Oct 2026 | Manufacturing problem | 3/16 | |
| Nebivolol | 1 | 21 Aug 2026 | Other | 4/16 | |
| Olmesartan Medoxomil | 1 | 7 Oct 2026 | Other | 5/16 | |
| Olmesartan Medoxomil and Diuretics | 1 | 27 Oct 2026 | Other | 4/16 | |
| Perindopril and Diuretics | 1 | 24 Aug 2026 | Other | 6/16 | |
| Rasagiline | 1 | 17 May 2026 | Manufacturing problem | 2/16 | |
| Risperidone | 1 | 9 Oct 2026 | Not stated | 13/16 | |
| Rosuvastatin | 1 | 4 Jun 2026 | Not stated | 12/16 | |
| Sildenafil | 1 | 16 Oct 2026 | Manufacturing problem | 10/16 | |
| Simvastatin and Ezetimibe | 1 | 5 Oct 2026 | Other | 8/16 | |
| Tramadol and Paracetamol | 1 | 23 Oct 2026 | Manufacturing problem | 5/16 | |
| Valsartan and Diuretics | 1 | 29 Oct 2026 | Manufacturing problem | 7/16 | |
| Vardenafil | 1 | 23 Oct 2026 | Manufacturing problem | 6/16 | |
| Ziprasidone | 1 | 17 Jun 2026 | Not stated | 7/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.